Three-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies.


Journal

Nature biomedical engineering
ISSN: 2157-846X
Titre abrégé: Nat Biomed Eng
Pays: England
ID NLM: 101696896

Informations de publication

Date de publication:
09 2020
Historique:
received: 19 02 2019
accepted: 21 05 2020
pubmed: 1 7 2020
medline: 18 11 2020
entrez: 1 7 2020
Statut: ppublish

Résumé

Microscopy analysis of tumour samples is commonly performed on fixed, thinly sectioned and protein-labelled tissues. However, these examinations do not reveal the intricate three-dimensional structures of tumours, nor enable the detection of aberrant transcripts. Here, we report a method, which we name DIIFCO (for diagnosing in situ immunofluorescence-labelled cleared oncosamples), for the multimodal volumetric imaging of RNAs and proteins in intact tumour volumes and organoids. We used DIIFCO to spatially profile the expression of diverse coding RNAs and non-coding RNAs at the single-cell resolution in a variety of cancer tissues. Quantitative single-cell analysis revealed spatial niches of cancer stem-like cells, and showed that the niches were present at a higher density in triple-negative breast cancer tissue. The improved molecular phenotyping and histopathological diagnosis of cancers may lead to new insights into the biology of tumours of patients.

Identifiants

pubmed: 32601394
doi: 10.1038/s41551-020-0576-z
pii: 10.1038/s41551-020-0576-z
doi:

Substances chimiques

Biomarkers, Tumor 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

875-888

Références

Andor, N. et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat. Med. 22, 105–113 (2016).
pubmed: 26618723 doi: 10.1038/nm.3984
Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573–582 (2014).
pubmed: 24816253 doi: 10.1038/ng.2983
Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883–892 (2012).
pubmed: 22397650 pmcid: 4878653 doi: 10.1056/NEJMoa1113205
Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373–386 (2018).
pubmed: 29224780 doi: 10.1016/j.cell.2017.11.010
Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).
pubmed: 23539594 pmcid: 3749880 doi: 10.1126/science.1235122
McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15–26 (2015).
pubmed: 25584892 doi: 10.1016/j.ccell.2014.12.001
Uhlen, P. & Tanaka, N. Improved pathological examination of tumors with 3D light-sheet microscopy. Trends Cancer 4, 337–341 (2018).
pubmed: 29709257 doi: 10.1016/j.trecan.2018.03.003
Tanaka, N. et al. Whole-tissue biopsy phenotyping of three-dimensional tumours reveals patterns of cancer heterogeneity. Nat. Biomed. Eng. 1, 796–806 (2017).
pubmed: 31015588 doi: 10.1038/s41551-017-0139-0
Chen, F. et al. Nanoscale imaging of RNA with expansion microscopy. Nat. Methods 13, 679–684 (2016).
pubmed: 27376770 pmcid: 4965288 doi: 10.1038/nmeth.3899
Choi, H. M. T. et al. Programmable in situ amplification for multiplexed imaging of mRNA expression. Nat. Biotechnol. 28, 1208–1212 (2010).
pubmed: 21037591 pmcid: 3058322 doi: 10.1038/nbt.1692
Lovett-Barron, M. et al. Ancestral circuits for the coordinated modulation of brain state. Cell 171, 1411–1423 (2017).
pubmed: 29103613 pmcid: 5725395 doi: 10.1016/j.cell.2017.10.021
Choi, H. M. T. et al. Mapping a multiplexed zoo of mRNA expression. Development 143, 3632–3637 (2016).
pubmed: 27702788 pmcid: 5087610 doi: 10.1242/dev.140137
Choi, H. M. T. et al. Third-generation in situ hybridization chain reaction: multiplexed, quantitative, sensitive, versatile, robust. Development 145, dev165753 (2018).
Stefanits, H. et al. KINFix—A formalin-free non-commercial fixative optimized for histological, immunohistochemical and molecular analyses of neurosurgical tissue specimens. Clin. Neuropathol. 35, 3–12 (2016).
pubmed: 26521938 doi: 10.5414/NP300907
Kap, M. et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. Plos ONE 6, e27704 (2011).
Lykidis, D. et al. Novel zinc-based fixative for high quality DNA, RNA and protein analysis. Nucleic Acids Res. 35, e85 (2007).
Wester, K. et al. Zinc-based fixative improves preservation of genomic DNA and proteins in histoprocessing of human tissues. Lab. Invest. 83, 889–899 (2003).
pubmed: 12808124 doi: 10.1097/01.LAB.0000074892.53211.A5
Sylwestrak, E. L., Rajasethupathy, P., Wright, M. A., Jaffe, A. & Deisseroth, K. Multiplexed intact-tissue transcriptional analysis at cellular resolution. Cell 164, 792–804 (2016).
pubmed: 26871636 pmcid: 4775740 doi: 10.1016/j.cell.2016.01.038
Renier, N. et al. Mapping of brain activity by automated volume analysis of immediate early genes. Cell 165, 1789–1802 (2016).
pubmed: 27238021 pmcid: 4912438 doi: 10.1016/j.cell.2016.05.007
Hatzis, C. et al. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J. Natl Cancer Inst. 103, 1871–1883 (2011).
pubmed: 22034635 pmcid: 3243675 doi: 10.1093/jnci/djr438
Snippert, H. J. et al. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 136, 2187–2194 (2009).
pubmed: 19324043 doi: 10.1053/j.gastro.2009.03.002
Medema, J. P. Cancer stem cells: the challenges ahead. Nat. Cell Biol. 15, 338–344 (2013).
pubmed: 23548926 doi: 10.1038/ncb2717
Brugnoli, F., Grassilli, S., Al-Qassab, Y., Capitani, S. & Bertagnolo, V. CD133 in breast cancer cells: more than a stem cell marker. J. Oncol. 2019, 7512632 (2019).
pubmed: 31636668 pmcid: 6766124 doi: 10.1155/2019/7512632
Joseph, C. et al. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer. Breast Cancer Res. Treat. 174, 387–399 (2019).
pubmed: 30554343 doi: 10.1007/s10549-018-05085-9
Liu, T. J. et al. CD133
pubmed: 22469978 doi: 10.1038/onc.2012.85
Panaccione, A., Guo, Y., Yarbrough, W. G. & Ivanov, S. V. Expression profiling of clinical specimens supports the existence of neural progenitor-like stem cells in basal breast cancers. Clin. Breast Cancer 17, 298–306 (2017).
pubmed: 28216417 pmcid: 5482752 doi: 10.1016/j.clbc.2017.01.007
Iwai, Y., Hamanishi, J., Chamoto, K. & Honjo, T. Cancer immunotherapies targeting the PD-1 signaling pathway. J. Biomed. Sci. 24, 26 (2017).
pubmed: 28376884 pmcid: 5381059 doi: 10.1186/s12929-017-0329-9
Anastasiadou, E., Jacob, L. S. & Slack, F. J. Non-coding RNA networks in cancer. Nat. Rev. Cancer 18, 5–18 (2018).
pubmed: 29170536 doi: 10.1038/nrc.2017.99
Schmitt, A. M. & Chang, H. Y. Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452–463 (2016).
pubmed: 27070700 pmcid: 4831138 doi: 10.1016/j.ccell.2016.03.010
Arun, G. et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 30, 34–51 (2016).
pubmed: 26701265 pmcid: 4701977 doi: 10.1101/gad.270959.115
Xue, M., Chen, W. & Li, X. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J. Cancer Res. Clin. Oncol. 142, 1407–1419 (2016).
pubmed: 26341664 doi: 10.1007/s00432-015-2042-y
Weber, J. et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N. Engl. J. Med. 377, 1824–1835 (2017).
pubmed: 28891423 doi: 10.1056/NEJMoa1709030
Uhlen, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
pubmed: 25613900 doi: 10.1126/science.1260419
Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).
pubmed: 27315476 doi: 10.1016/j.cell.2016.05.082
Choi, H. M., Beck, V. A. & Pierce, N. A. Next-generation in situ hybridization chain reaction: higher gain, lower cost, greater durability. ACS Nano 8, 4284–4294 (2014).
pubmed: 24712299 pmcid: 4046802 doi: 10.1021/nn405717p
Han, R., Chen, S., Wang, J., Zhao, Y. & Li, G. LncRNA UCA1 affects epithelial–mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells. Cell Cycle 18, 3044–3053 (2019).
pubmed: 31537148 pmcid: 6791705 doi: 10.1080/15384101.2019.1667707
Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer 18, 128–134 (2018).
pubmed: 29326430 doi: 10.1038/nrc.2017.118
Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463–468 (2018).
pubmed: 29670281 doi: 10.1038/s41586-018-0040-3
Gutschner, T. et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 73, 1180–1189 (2013).
pubmed: 23243023 doi: 10.1158/0008-5472.CAN-12-2850
Murrow, L. M. et al. Mapping the complex paracrine response to hormones in the human breast at single-cell resolution. Preprint at bioRxiv https://doi.org/10.1101/430611 (2020).
Diggle, P. J. Statistical Analysis of Spatial Point Patterns (Academic, 1983).
Park, Y. G. et al. Protection of tissue physicochemical properties using polyfunctional crosslinkers. Nat. Biotechnol. 37, 73–83 (2019).
doi: 10.1038/nbt.4281
Azaripour, A. et al. A survey of clearing techniques for 3D imaging of tissues with special reference to connective tissue. Prog. Histochem. Cytochem. 51, 9–23 (2016).
pubmed: 27142295 doi: 10.1016/j.proghi.2016.04.001
Kreso, A. & Dick, J. E. Evolution of the cancer stem cell model. Cell Stem Cell 14, 275–291 (2014).
pubmed: 24607403 doi: 10.1016/j.stem.2014.02.006
Nassar, D. & Blanpain, C. Cancer stem cells: basic concepts and therapeutic implications. Annu Rev. Pathol. 11, 47–76 (2016).
pubmed: 27193450 doi: 10.1146/annurev-pathol-012615-044438
O’Brien, C. A., Pollett, A., Gallinger, S. & Dick, J. E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445, 106–110 (2007).
pubmed: 17122772 doi: 10.1038/nature05372
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
pubmed: 12629218 doi: 10.1073/pnas.0530291100 pmcid: 153034
Lathia, J. D. & Liu, H. Overview of cancer stem cells and stemness for community oncologists. Target Oncol. 12, 387–399 (2017).
pubmed: 28664387 pmcid: 5524873 doi: 10.1007/s11523-017-0508-3
Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124–1134 (2017).
doi: 10.1038/nm.4409 pubmed: 28985214
Schulenburg, A. et al. Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? J. Hematol. Oncol. 8, 16 (2015).
pubmed: 25886184 pmcid: 4345016 doi: 10.1186/s13045-015-0113-9
Desai, A., Yan, Y. & Gerson, S. L. Concise reviews: cancer stem cell targeted therapies: toward clinical success. Stem Cells Transl. Med. 8, 75–81 (2019).
pubmed: 30328686 doi: 10.1002/sctm.18-0123
Prasad, S., Ramachandran, S., Gupta, N., Kaushik, I. & Srivastava, S. K. Cancer cells stemness: a doorstep to targeted therapy. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165424 (2020).
pubmed: 30818002 doi: 10.1016/j.bbadis.2019.02.019
Klonisch, T. et al. Cancer stem cell markers in common cancers—therapeutic implications. Trends Mol. Med. 14, 450–460 (2008).
pubmed: 18775674 doi: 10.1016/j.molmed.2008.08.003
Enderling, H. Cancer stem cells: small subpopulation or evolving fraction? Integr. Biol. 7, 14–23 (2015).
doi: 10.1039/C4IB00191E
Hoefflin, R. et al. Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity. Nat. Commun. 7, ncomms11845 (2016).
Neumeister, V., Agarwal, S., Bordeaux, J., Camp, R. L. & Rimm, D. L. In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am. J. Pathol. 176, 2131–2138 (2010).
pubmed: 20228222 pmcid: 2861079 doi: 10.2353/ajpath.2010.090712
Yang, F. et al. Evaluation of breast cancer stem cells and intratumor stemness heterogeneity in triple-negative breast cancer as prognostic factors. Int. J. Biol. Sci. 12, 1568–1577 (2016).
pubmed: 27994520 pmcid: 5166497 doi: 10.7150/ijbs.16874
Ricci-Vitiani, L. et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824–828 (2010).
pubmed: 21102434 doi: 10.1038/nature09557
Lancaster, M. A. & Knoblich, J. A. Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329–2340 (2014).
pubmed: 25188634 pmcid: 4160653 doi: 10.1038/nprot.2014.158
Camp, J. G. et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc. Natl Acad. Sci. USA 112, 15672–15677 (2015).
pubmed: 26644564 doi: 10.1073/pnas.1520760112 pmcid: 4697386
Uhlin, E. et al. Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions. Stem Cell Res. 18, 22–25 (2017).
pubmed: 28395796 doi: 10.1016/j.scr.2016.12.006
Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011).
pubmed: 21889923 doi: 10.1053/j.gastro.2011.07.050
Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nature 497, 332–337 (2013).
pubmed: 23575631 pmcid: 4092167 doi: 10.1038/nature12107
Tanaka, N. et al. Mapping of the three-dimensional lymphatic microvasculature in bladder tumours using light-sheet microscopy. Br. J. Cancer 118, 995–999 (2018).
pubmed: 29515257 pmcid: 5931093 doi: 10.1038/s41416-018-0016-y
Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat. Protoc. 9, 1682–1697 (2014).
pubmed: 24945384 pmcid: 4096681 doi: 10.1038/nprot.2014.123
Bria, A. & Iannello, G. TeraStitcher—a tool for fast automatic 3D-stitching of teravoxel-sized microscopy images. BMC Bioinformatics 13, 316 (2012).
pubmed: 23181553 pmcid: 3582611 doi: 10.1186/1471-2105-13-316
Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18, 529 (2017).
pubmed: 29187165 pmcid: 5708080 doi: 10.1186/s12859-017-1934-z
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019

Auteurs

Nobuyuki Tanaka (N)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. urotanaka@keio.jp.
Department of Urology, Keio University School of Medicine, Tokyo, Japan. urotanaka@keio.jp.

Shigeaki Kanatani (S)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Dagmara Kaczynska (D)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Keishiro Fukumoto (K)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Lauri Louhivuori (L)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

Tomohiro Mizutani (T)

Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.

Oded Kopper (O)

Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.

Pauliina Kronqvist (P)

Department of Pathology, University of Turku, Turku, Finland.

Stephanie Robertson (S)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Claes Lindh (C)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Lorand Kis (L)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Robin Pronk (R)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Naoya Niwa (N)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Kazuhiro Matsumoto (K)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Mototsugu Oya (M)

Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Ayako Miyakawa (A)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden.

Anna Falk (A)

Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Johan Hartman (J)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.

Cecilia Sahlgren (C)

Turku Bioscience Centre, Åbo Akademi University and University of Turku, Turku, Finland.
Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland.
Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.

Hans Clevers (H)

Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.

Per Uhlén (P)

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. per.uhlen@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH